Utah Administrative Code
Topic - Health
Title R396 - Population Health
Rule R396-100 - Immunization Rule for Students
Section R396-100-3 - Required Immunizations

Universal Citation: UT Admin Code R 396-100-3

Current through Bulletin 2024-06, March 15, 2024

(1) A student enrolling in kindergarten through sixth grade shall be immunized in accordance with the Advisory Committee on Immunization Practices (ACIP) Recommendations, as listed in Subsection R396-100-3(4), before school entry for the following vaccines and doses:

(a) Measles, Mumps, Rubella (MMR)- 2 doses;

(b) Varicella- 2 doses;

(c) Hepatitis B- 3 doses;

(d) Polio- 4 doses, dose number 4 is not necessary if dose 3 was administered at age 4 years or older and at least 6 months after the previous dose;

(e) Hepatitis A- 2 doses; and

(f) Diphtheria, Tetanus, and Pertussis (DTaP)- 5 doses, dose 5 is not necessary if dose 4 was administered at age 4 years or older and at least 6 months after dose 3.

(2)

(a) A student enrolling in seventh through twelfth grade:

(b) Must be immunized in accordance with the ACIP Recommendations, as listed in Subsection R396-100-3(4), before school entry for the following vaccines and doses:
(i) Tetanus, Diphtheria, and acellular Pertussis (Tdap)-One dose;

(ii) Measles, Mumps, Rubella (MMR)- 2 doses;

(iii) Varicella- 2 doses;

(iv) Hepatitis B- 3 doses;

(v) Polio- 4 doses, dose 4 is not necessary if dose 3 was administered at age 4 years or older and at least 6 months after the previous dose;

(vi) Hepatitis A- 2 doses; and

(vii) Meningococcal Conjugate Vaccine- One dose.

(c) Must provide proof of previously receiving five doses of DTaP vaccine or 4 doses if dose 4 was administered at age 4 years or older and at least 6 months after dose 3. A student who has never been vaccinated with DTaP vaccine or who was not fully vaccinated with DTaP vaccine as provided by Subsection R396-100-3(1)(f), must be immunized with the appropriate number of doses of Tetanus, Diphtheria (Td) or Tdap vaccine in accordance with the catch-up Immunization schedule for children and adolescents who start late or who are more than one month behind.

(3) To attend a Utah early childhood program, a student must meet the minimum immunization requirements of the ACIP listed in Subsection R396-100-3(4) for the following antigens:

(a) Diphtheria;

(b) Tetanus;

(c) Pertussis;

(d) Polio;

(e) Measles;

(f) Mumps;

(g) Rubella;

(h) Haemophilus Influenza Type b;

(i) Hepatitis A;

(j) Hepatitis B;

(k) Pneumococcal; and

(l) Varicella vaccines before school entry.

(4) The vaccinations must be administered according to the recommendations of the United States Public Health Service's Advisory Committee on Immunization Practices (ACIP) which are incorporated by reference into this rule:

(a) General Recommendations on Immunization: MMWR, December 1, 2006/Vol. 55/No. RR-15;

(b) General Recommendations on Immunization: MMWR, January 28, 2011; 60(RR02):1-60;

(c) Immunization of Adolescents: MMWR, November 22, 1996/Vol. 45/No. RR-13;

(d) Combination Vaccines for Childhood Immunization: MMWR, May 14, 1999/Vol. 48/No. RR-5;

(e) Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series: Supplemental Recommendations of the Advisory Committee on Immunization Practices: MMWR November 17, 2000/Vol. 49/No. RR-13;

(f) Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants: MMWR, February 7, 2020, 69 (5);136-139;

(g) Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP): MMWR, April 27, 2018; 67 (2):1-44;

(h) Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010: MMWR, January 14, 2011; 60(01):13-15;

(i) Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents: MMWR, March 24, 2006, Vol. 55(RR03):1-49;

(j) Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices: MMWR, January 24, 2020, Vol. 69 (3);77-83;

(k) A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part 1: Immunization of Infants, Children and Adolescents: MMWR, December 23, 2005, Vol. 54(RR-16):1-39;

(l) Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices: MMWR, January 12, 2018; 67 (1); 1--31;

(m) Haemophilus b Conjugate Vaccines for Prevention of Haemophilus influenza Type b Disease Among Infants and Children Two Months of Age and Older: MMWR, January 11, 1991/Vol. 40/No. RR-1;

(n) Recommendations for Use of Haemophilus b Conjugate Vaccines and a Combined Diphtheria, Tetanus, and Pertussis, and Haemophilus b Vaccine: MMWR, September 17, 1993/Vol. 42/No. RR-13;

(o) Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports: MMWR, February 28, 2014; 63(RR01):1-14;

(p) Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) for the Control and Elimination of Mumps: MMWR, June 9, 2006/Vol. 55/No. RR-22;

(q) Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices --- United States, 2022: MMWR, November 18, 2022, 71 (46); 1465-1470;

(r) Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP): MMWR, June 14, 2013; 62(RR04):1-34;

(s) Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices: MMWR, May 7, 2010; 59(RR--3):1 -- 16;

(t) Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Routine Poliovirus Vaccination: MMWR, August 7, 2009/Vol. 58/No. 30;

(u) Poliomyelitis Prevention in the United States: MMWR May 19, 2000 / Vol. 49 / No. RR-05;

(v) Prevention of Varicella: MMWR, June 22, 2007/Vol. 56/No. RR-4;

(w) Prevention of Hepatitis A Through Active or Passive Immunization: MMWR, May 29, 2006/Vol. 55/No. RR-7;

(x) Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices: MMWR, July 3, 2020, Vol. 69 (5);1-38;

(y) Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children-Advisory Committee on Immunization Practices, (ACIP), 2010: MMWR March 12, 2010/Vol. 59/No. 09;

(z) Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices-US, 2022: MMWR, September 16, 2022, 71(37);1174--1181;

(aa) Preventing Pneumococcal Disease Among Infants and Young Children: MMWR October 6, 2000 /Vol. 49 / No. RR-09;

(bb) Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP): March 22, 2013/62(RR02);1-22;

(cc) Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices: MMWR, September 25, 2020, Volume 69(9); 1--41;

(dd) Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010: MMWR, March 12, 2010; 59(09):273; and

(ee) Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010: MMWR, January 28, 2011; 60(03):72-76.

Disclaimer: These regulations may not be the most recent version. Utah may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.